BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24643079)

  • 1. Microglia is a key player in the reduction of stroke damage promoted by the new antithrombotic agent ticagrelor.
    Gelosa P; Lecca D; Fumagalli M; Wypych D; Pignieri A; Cimino M; Verderio C; Enerbäck M; Nikookhesal E; Tremoli E; Abbracchio MP; Sironi L
    J Cereb Blood Flow Metab; 2014 Jun; 34(6):979-88. PubMed ID: 24643079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propofol protects against focal cerebral ischemia via inhibition of microglia-mediated proinflammatory cytokines in a rat model of experimental stroke.
    Zhou R; Yang Z; Tang X; Tan Y; Wu X; Liu F
    PLoS One; 2013; 8(12):e82729. PubMed ID: 24349350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ticagrelor in a mouse model of ischemic stroke.
    Yamauchi K; Imai T; Shimazawa M; Iwama T; Hara H
    Sci Rep; 2017 Sep; 7(1):12088. PubMed ID: 28935927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effects of angiotensin-(1-7) in ischemic stroke.
    Regenhardt RW; Desland F; Mecca AP; Pioquinto DJ; Afzal A; Mocco J; Sumners C
    Neuropharmacology; 2013 Aug; 71():154-63. PubMed ID: 23583926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competitive mode and site of interaction of ticagrelor at the human platelet P2Y12 -receptor.
    Hoffmann K; Lutz DA; Straßburger J; Baqi Y; Müller CE; von Kügelgen I
    J Thromb Haemost; 2014 Nov; 12(11):1898-905. PubMed ID: 25186974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ticagrelor, but not clopidogrel, reduces arterial thrombosis via endothelial tissue factor suppression.
    Reiner MF; Akhmedov A; Stivala S; Keller S; Gaul DS; Bonetti NR; Savarese G; Glanzmann M; Zhu C; Ruf W; Yang Z; Matter CM; Lüscher TF; Camici GG; Beer JH
    Cardiovasc Res; 2017 Jan; 113(1):61-69. PubMed ID: 28028070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scutellarin Exerts Anti-Inflammatory Effects in Activated Microglia/Brain Macrophage in Cerebral Ischemia and in Activated BV-2 Microglia Through Regulation of MAPKs Signaling Pathway.
    Chen HL; Jia WJ; Li HE; Han H; Li F; Zhang XL; Li JJ; Yuan Y; Wu CY
    Neuromolecular Med; 2020 Jun; 22(2):264-277. PubMed ID: 31792810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
    Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L
    Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raf Kinase Inhibitor Protein Attenuates Ischemic-Induced Microglia Cell Apoptosis and Activation Through NF-κB Pathway.
    Su L; Zhang R; Chen Y; Zhu Z; Ma C
    Cell Physiol Biochem; 2017; 41(3):1125-1134. PubMed ID: 28245468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calycosin Preserves BDNF/TrkB Signaling and Reduces Post-Stroke Neurological Injury after Cerebral Ischemia by Reducing Accumulation of Hypertrophic and TNF-α-Containing Microglia in Rats.
    Hsu CC; Kuo TW; Liu WP; Chang CP; Lin HJ
    J Neuroimmune Pharmacol; 2020 Jun; 15(2):326-339. PubMed ID: 31927682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats.
    Shi QJ; Wang H; Liu ZX; Fang SH; Song XM; Lu YB; Zhang WP; Sa XY; Ying HZ; Wei EQ
    Neuroscience; 2015 Apr; 291():53-69. PubMed ID: 25681271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallic acid attenuates cerebral ischemia/re-perfusion-induced blood-brain barrier injury by modifying polarization of microglia.
    Qu Y; Wang L; Mao Y
    J Immunotoxicol; 2022 Dec; 19(1):17-26. PubMed ID: 35254962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-377 Regulates Inflammation and Angiogenesis in Rats After Cerebral Ischemic Injury.
    Fan Y; Ding S; Sun Y; Zhao B; Pan Y; Wan J
    J Cell Biochem; 2018 Jan; 119(1):327-337. PubMed ID: 28569430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction.
    Ye Y; Birnbaum GD; Perez-Polo JR; Nanhwan MK; Nylander S; Birnbaum Y
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1805-14. PubMed ID: 26044583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets.
    Gasecka A; Nieuwland R; van der Pol E; Hajji N; Ćwiek A; Pluta K; Konwerski M; Filipiak KJ
    Cardiol J; 2019; 26(6):782-789. PubMed ID: 29671861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer.
    Gebremeskel S; LeVatte T; Liwski RS; Johnston B; Bezuhly M
    Int J Cancer; 2015 Jan; 136(1):234-40. PubMed ID: 24798403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory effects of Edaravone and Scutellarin in activated microglia in experimentally induced ischemia injury in rats and in BV-2 microglia.
    Yuan Y; Zha H; Rangarajan P; Ling EA; Wu C
    BMC Neurosci; 2014 Nov; 15():125. PubMed ID: 25416145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial P2Y12 deficiency/inhibition protects against brain ischemia.
    Webster CM; Hokari M; McManus A; Tang XN; Ma H; Kacimi R; Yenari MA
    PLoS One; 2013; 8(8):e70927. PubMed ID: 23940669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of angiotensin II and its receptors in activated microglia in experimentally induced cerebral ischemia in the adult rats.
    Wu CY; Zha H; Xia QQ; Yuan Y; Liang XY; Li JH; Guo ZY; Li JJ
    Mol Cell Biochem; 2013 Oct; 382(1-2):47-58. PubMed ID: 23754618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice.
    Ganbaatar B; Fukuda D; Salim HM; Nishimoto S; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Soeki T; Sata M
    Atherosclerosis; 2018 Aug; 275():124-132. PubMed ID: 29902700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.